Abstract
HER-2, a protooncogene located on chromosome 17q21, encodes a transmembrane glycoprotein (p185) with tyrosine kinase activity. Alterations of the HER-2 gene have been implicated in the carcinogenesis and prognosis of breast cancer and other solid tumors. It is also a cancer-therapeutic target for antibody-based therapy against the HER-2 protein. A single-nucleotide polymorphism (SNP) at codon 655, resulting in a G-to-A transition (Ile655Val) in the transmembrane domain-coding region of this gene has been associated with an increased risk of breast cancer, particularly among younger women. To understand the importance of this finding throughout the world, we evaluated this polymorphism in Ghanaian, Kenyan, Sudanese, Caucasian, African–American, Saudi, and Filipino subjects using a polymerase chain reaction-restriction fragment length polymorphism assay. The frequency of the Val allele, which is associated with increased breast cancer risk, was highly variable between populations (0%–24%). Continental African populations had a lower frequency of the Val allele than did Saudi, Chinese, Filipino, Caucasian, and African–American subjects. The data suggest that this SNP has variable frequency in different ethnic groups. The findings in this study correspond with the lower incidence and lower risk of breast cancer in African women compared with Caucasian and African–American women.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: December 13, 2001 / Accepted: January 16, 2002
Rights and permissions
About this article
Cite this article
Ameyaw, MM., Tayeb, M., Thornton, N. et al. Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer. J Hum Genet 47, 172–175 (2002). https://doi.org/10.1007/s100380200019
Issue Date:
DOI: https://doi.org/10.1007/s100380200019
This article is cited by
-
Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer
Journal of Genetic Engineering and Biotechnology (2021)
-
HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis
Breast Cancer Research and Treatment (2009)
-
The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population
BMC Cancer (2008)
-
TGFβ1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFβ1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy
Breast Cancer Research and Treatment (2008)
-
Differential Expression of HER-2/NEU Receptor of Invasive Mammary Carcinoma Between Caucasian and African American patients in the Detroit Metropolitan Area. Correlation with Overall Survival and Other Prognostic Factors
Breast Cancer Research and Treatment (2006)